MedTrace Logo

Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF

NCT02755441 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2023-12-22

No results posted yet for this study

Summary

Incident patients with idiopathic pulmonary fibrosis (IPF) in Denmark will be offered inclusion and followed up for up to 5 years with measurements of blood biomarkers and measurements of disease progression.

Conditions

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • Nordic Bioscience A/S

    collaborator INDUSTRY

  • Nils Hoyer

    lead OTHER

Principal Investigators

  • Nils Hoyer, MD · Gentofte Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2023-12-31
Completion
2028-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02755441 on ClinicalTrials.gov